Consolidated Statements of Changes in Equity (USD $)	Total	Common Stock	Additional Paid-in capital	Retained Earnings	Statutory Reserve	Accumulated Other Comprehensive Income	Total Stockholders' Equity	Non-Controlling Interest
Beginning Balance at Dec. 31, 2010	$ 10,334,146	$ 10,758	$ 1,417,098	$ 5,832,077	$ 373,406	$ 530,070	$ 8,163,409	$ 2,170,737
Beginning Balance, shares at Dec. 31, 2010		10,758,000
Effect of acquisition of China Flying	(72,110)		2,133,917			(35,290)	2,098,627	(2,170,737)
Effect of Share Exchange Agreement	54,599	399	54,200				54,599
Effect of Share Exchange Agreement, shares		399,180
Effect of Private Placement	6,125,195		6,125,195				6,125,195
Shares issued for consulting services	2,491,938	2,167	2,489,771				2,491,938
Shares issued for consulting services, shares		2,166,903
Net loss	(3,136,094)			(3,136,094)			(3,136,094)
Foreign currency translation	56,629					56,629	56,629
Balance at Dec. 31, 2011	15,854,303	13,324	12,220,181	2,695,983	373,406	551,409	15,854,303
Balance, Shares at Dec. 31, 2011		13,324,083
Net loss	(229,006)			(210,247)			(210,247)	(18,759)
Foreign currency translation	107,589					107,461	107,461	128
60% investment on Qingyuan Tanke Bio-Technology	190,074							190,074
Balance at Dec. 31, 2012	$ 15,922,960	$ 13,324	$ 12,220,181	$ 2,485,736	$ 373,406	$ 658,870	$ 15,751,517	$ 171,443
Balance, Shares at Dec. 31, 2012		13,324,083